Eventide Asset Management Reports 4.5% Stake in Collegium Pharmaceutical, Inc. (COLL)

On May 15, 2026, Eventide Asset Management, LLC, along with Dr. Finny Kuruvilla and Robin C. John, filed a Schedule 13G/A regarding their holdings in Collegium Pharmaceutical, Inc. (COLL). The filing indicates that the group now beneficially owns 1,424,282 shares of Common Stock, representing 4.5% of the company. This reflects an increase from a previous position of 0.0%, indicating a new significant stake or a restoration of a previously exited position. Eventide Asset Management exercises sole voting and dispositive power over the 1,424,282 shares, while Dr. Kuruvilla and Mr. John share voting and dispositive power in their capacities as control persons. The securities were acquired in the ordinary course of business and not for the purpose of influencing or changing the control of the issuer. The filing represents the eighth amendment to their Schedule 13G, with the event date triggering the filing recorded as March 31, 2026. All reporting persons are based in Boston, Massachusetts.